Buy Kits EyeCare for a 3-5 Year Runway to Compound Value

about 2 months ago

Adam Wilk

"Kits is our founder-led e-commerce eye care business that has grown tremendously since inception. If Kits can approach my estimate of cash flows during the next 3-5 years, shares could trade between $35 to $45 CAD per share versus $15 CAD today."

Kits EyeCare is highlighted as an emerging long-term compounder with a clear catalyst in its revenue mix shift and cost discipline. The significant upside from a current level of $15 CAD to a potential trading range of $35-$45 CAD over the next 3-5 years makes it an actionable buy for investors.